Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 65

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 65
---
 conflicts with any duties with respect
to the debt securities, the trustee is required to either resign or eliminate such conflicting interest to the extent and in the manner
provided by the indenture.

<div align='center'>18

DESCRIPTION OF
WARRANTS WE MAY OFFER</div>

We may issue warrants for the purchase of debt
securities, preferred stock or common stock. Warrants may be issued independently or together with debt securities, preferred stock or
common stock and may be attached to or separate from any offered securities. Any issue of warrants will be governed by the terms of the
applicable form of warrant and any related warrant agreement which we will file with the SEC and they will be incorporated by reference
to the registration statement of which this prospectus is a part on or before the time we issue any warrants.

The particular terms of any issue of warrants
will be described in the prospectus supplement relating to the issue. Those terms may include:

| ● | the title of such warrants; |

| ● | the aggregate number of such warrants; |

| ● | the price or prices at which such warrants will be issued; |

| ● | the currency or currencies (including composite currencies) in which the price of such warrants may be payable; |

| ● | the terms of the securities purchasable upon exercise of such warrants and the procedures and conditions relating to the exercise 
 of such warrants;                                                                                                                 |

| ● | the price at which the securities purchasable upon exercise of such warrants may be purchased; |

| ● | the date on which the right to exercise such warrants will commence and the date on which such right shall expire; |

| ● | any provisions for adjustment of the number or amount of securities receivable upon exercise of the warrants or the exercise price 
 of the warrants;                                                                                                                   |

| ● | if applicable, the minimum or maximum amount of such warrants that may be exercised at any one time; |

| ● | if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued 
 with each such security;                                                                                                              |

| ● | if applicable, the date on and after which such warrants and the related securities will be separately transferable; |

| ● | information with respect to book-entry procedures, if any; and |

| ● | any other terms of such warrants, including terms, procedures and limitations relating to the exchange or exercise of such warrants. |

The prospectus supplement relating to any warrants
to purchase equity securities may also include